Skip to content
Review Open access

The NLRP3 inflammasome in physiological and dysfunctional host response in human sepsis and critical illness: a narrative review

Sep 2026 · Critical Care · Vol 30 · 1 citation · ⚡ 1 influential · 263 references
Medicine

TL;DR

Although targeted modulation of inflammasome pathways represents a promising therapeutic strategy, further research is needed to refine patient selection, identify reliable biomarkers, and better characterise disease heterogeneity to enable successful clinical translation.

Abstract

The NLRP3 inflammasome is a cytosolic multiprotein complex that serves as a key regulator of innate immunity by reacting to pathogen- and damage-associated signals and orchestrating downstream inflammatory responses. Inflammasome activation induces caspase-1-dependent maturation of interleukin (IL)-1β, IL-18 and gasdermin D, which results in pyroptotic cell death. While tightly controlled inflammasome activation is essential for effective host defence and pathogen clearance, accumulating evidence implicates its dysregulation as a central driver of host response imbalance in critical illness. In conditions such as sepsis and acute respiratory distress syndrome, excessive activation contributes to hyperinflammation, endothelial dysfunction, immunothrombosis, and multi-organ failure. Conversely, insufficient or exhausted inflammasome responses may impair microbial clearance and predispose to secondary infections. These observations underscore the context-dependent and temporally dynamic role of inflammasome signalling as being either protective or pathogenic. Emerging therapeutic strategies aim to restore immune homeostasis through targeted modulation of inflammasome pathways, including IL-1 blockade (e.g., anakinra) and inhibition of upstream signalling components. However, clinical translation remains challenging, requiring improved patient stratification, biomarker-guided approaches, and a deeper understanding of disease heterogeneity. Inflammasome signalling plays a highly dynamic role in critical illness, contributing to effective host defence, if functional, or to pathological inflammation, if dysregulated. Although targeted modulation of inflammasome pathways represents a promising therapeutic strategy, further research is needed to refine patient selection, identify reliable biomarkers, and better characterise disease heterogeneity to enable successful clinical translation.

Read PDF

Similar papers

Review Open access Oct 2026

Inflammasomes in respiratory diseases: from disease pathogenesis to drug development and use of multi-omics

Inflammasomes are pivotal for the initiation and control of host inflammatory responses. This is particularly important in the respiratory system due to its direct exposure to noxious environmental and infectious stimuli, which can cause local inflammation, tissue damage and impaired function. Inflammasomes are activat...

R. Shipley, Matthew O'Rourke, Sobia Idrees et al. · 0 citations
Review Open access Sep 2026

Crosstalk between innate immune signaling pathways and integrated TLR, NLRP3 inflammasome, cGAS–STING, and NF-κB networks in sepsis

This review comprehensively examines the molecular architecture and dynamic interactions among these signaling networks, highlighting the shared adaptor proteins, regulatory feedback loops, and signaling hubs that determine the transition from protective host defense to uncontrolled hyperinflammation and subsequent imm...

Xiao-Xi Du, Han-Chua Qiao · 0 citations
Review Open access Sep 2026

The NLRP3 inflammasome at the crossroads of innate immune signaling and cell death

Recent advances in the understanding of the molecular mechanisms that mediate interactions between NLRP3 and other inflammasome-associated pathways are summarized, focusing on shared signaling components, organelle dynamics, posttranslational modifications, and feedback regulatory circuits.

Nan-Yang Xiao, Ze-Xuan Lu, D. Cooper et al. · 0 citations
Review Sep 2026

Inflammasome-autophagy crosstalk in the tumor microenvironment.

This review integrates traditionally studied pathways into a unified NLRP3-autophagy-mitochondrial stress axis and examines how its stage-, cell-, and context-dependent regulation determines tumor fate.

Pratyasha Mahadani, Sushmita Patra, B. S. Patro et al. · 0 citations
Sep 2026

NNV mediates the activation of the NLRP3 inflammasome through mtDNA release and oxidative DNA damage.

The NLRP3 inflammasome is a cytoplasmic multiprotein complex that is activated under stress or infection conditions. It promotes the maturation of IL-1β by cleaving pro-Caspase-1, thereby playing a critical role in host innate immune responses. Various viruses can differentially activate NLRP3 through distinct mechanis...

Li-Fang Cao, Run-Bin Huang, Lu Yang et al. · 0 citations
Open access Sep 2026

Inflammasomes and Their Role in Infectious and Autoimmune Diseases

The structure, activation, and functions of such important sensors as NLRP1, NLRP3, AIM2, and pyrin are described and their involvement in pathogenesis of diseases as rheumatoid arthritis, type 1 diabetes, atherosclerosis, COVID-19, toxoplasmosis, and malaria is discussed.

Mahnoor Ijaz, Soban Arif, Fatima Tariq et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.